Examining the Volatility of Allakos Inc’s (ALLK) Stock

The stock of Allakos Inc (ALLK) has seen a -2.04% decrease in the past week, with a -69.42% drop in the past month, and a -80.41% decrease in the past quarter. The volatility ratio for the week is 4.88%, and the volatility levels for the past 30 days are at 13.33% for ALLK. The simple moving average for the past 20 days is -49.44% for ALLK’s stock, with a -71.49% simple moving average for the past 200 days.

Is It Worth Investing in Allakos Inc (NASDAQ: ALLK) Right Now?

ALLK has 36-month beta value of 0.74. Analysts have mixed views on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 7 as “hold,” and 0 as “sell.”

The public float for ALLK is 74.52M, and currently, short sellers hold a 3.27% ratio of that float. The average trading volume of ALLK on February 13, 2025 was 2.13M shares.

ALLK) stock’s latest price update

The stock price of Allakos Inc (NASDAQ: ALLK) has plunged by -2.47 when compared to previous closing price of 0.27, but the company has seen a -2.04% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-02-11 that SOUTH SAN FRANCISCO, Calif., Feb. 11, 2025 (GLOBE NEWSWIRE) — Lycia Therapeutics, Inc., a biotechnology company developing lysosomal targeting chimera (LYTAC)-based protein degradation therapies to eliminate disease at its source, today announced the appointment of Chin Lee, M.D.

Analysts’ Opinion of ALLK

Many brokerage firms have already submitted their reports for ALLK stocks, with Jefferies repeating the rating for ALLK by listing it as a “Hold.” The predicted price for ALLK in the upcoming period, according to Jefferies is $1.50 based on the research report published on January 17, 2024 of the previous year 2024.

ALLK Trading at -69.82% from the 50-Day Moving Average

After a stumble in the market that brought ALLK to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -84.35% of loss for the given period.

Volatility was left at 13.33%, however, over the last 30 days, the volatility rate increased by 4.88%, as shares sank -70.00% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -73.81% lower at present.

During the last 5 trading sessions, ALLK fell by -2.04%, which changed the moving average for the period of 200-days by -73.81% in comparison to the 20-day moving average, which settled at $0.5231. In addition, Allakos Inc saw -78.14% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at ALLK starting from Tomasi Adam, who proposed sale 21,116 shares at the price of $1.10 back on Dec 06 ’24. After this action, Tomasi Adam now owns shares of Allakos Inc, valued at $23,219 using the latest closing price.

Radford Harlan Baird, the Officer of Allakos Inc, proposed sale 13,138 shares at $1.10 during a trade that took place back on Dec 06 ’24, which means that Radford Harlan Baird is holding shares at $14,447 based on the most recent closing price.

Stock Fundamentals for ALLK

Current profitability levels for the company are sitting at:

  • -14.79 for the present operating margin
  • 0.68 for the gross margin

The net margin for Allakos Inc stands at -16.62. The total capital return value is set at -1.47. Equity return is now at value -121.68, with -87.64 for asset returns.

Based on Allakos Inc (ALLK), the company’s capital structure generated 0.35 points at debt to capital in total, while cash flow to debt ratio is standing at -2.7. The debt to equity ratio resting at 0.54. The interest coverage ratio of the stock is -60.21.

Currently, EBITDA for the company is -189.91 million with net debt to EBITDA at -0.18. When we switch over and look at the enterprise to sales, we see a ratio of 4.85. The liquidity ratio also appears to be rather interesting for investors as it stands at 6.08.

Conclusion

To put it simply, Allakos Inc (ALLK) has had a bad performance in recent times. Analysts have a mixed opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.

Related Posts